Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients

BACKGROUND: Growing evidence supports the modulatory role of human gut microbiome on neoadjuvant chemotherapy (NAC) efficacy. However, the relationships among the gut microbiome, tumor-infiltrating lymphocytes (TILs), and NAC response for breast cancer (BC) patients remain unclear. We thus proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuanyuan, Dong, Bingbin, Wu, Wei, Wang, Jiawei, Jin, Hao, Chen, Kangmei, Huang, Kangling, Huang, Songyin, Yao, Yandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010823/
https://www.ncbi.nlm.nih.gov/pubmed/35433455
http://dx.doi.org/10.3389/fonc.2022.865121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010823/
https://www.ncbi.nlm.nih.gov/pubmed/35433455
http://dx.doi.org/10.3389/fonc.2022.865121

Ejemplares similares